by The Economist
My articles My siteMy videosMy books
Follow on:LinkedINTwitterFacebookYoutubeAmazonGoogle +
| The race to immunise the global population against covid-19 is under way. With the distribution of safe and effective vaccines posing an unprecedented challenge, what are the key obstacles to overcome? Keep up to date with The Economist’s coverage of the coronavirus: https://econ.st/2Y5BxxW Track covid-19 vaccine rollouts around the world: https://econ.st/3o3t74w Sign up to The Economist’s daily newsletter to to read stories about covid-19 and its consequences: https://econ.st/2Ckne0X Read why China’s jabs may have an important role in the fight against covid-19: https://econ.st/2Y4rCZj How fast can vaccination against covid-19 make a difference? https://econ.st/3qKigy4 How can America meet its covid-19 vaccination targets? https://econ.st/39ZtUhM The EU should stop ignoring the vaccine race and try and win it: https://econ.st/3iDk7Sr How will the new variants of covid-19 affect the vaccines? https://econ.st/3qE4PzC Covid-19 vaccination is a marathon not a sprint. Governments need to think about what comes next: https://econ.st/3oanGRt Read about how politics is interfering with vaccination drives in Asia: https://econ.st/365Wxsx Why vaccine campaigns are so hard—but crucial to get right: https://econ.st/364aIP4 Why Bahrain and the UAE are relying on a Chinese-made vaccine: https://econ.st/3odqxZD |
The Economist offers authoritative insight and opinion on international news, politics, business, finance, science, technology and the connections between them.
Tags: Featured
